The Rise of Agentic AI: A Highlight from the 2025 Veeva Commercial Summit
November 5, 2025 - 23:53
Agentic AI was a point of emphasis on the first day of the 2025 Veeva Commercial Summit held in Madrid, Spain. Industry leaders gathered to discuss the transformative potential of this advanced technology, which is expected to revolutionize various sectors. Agentic AI refers to systems that possess a degree of autonomy and can make decisions based on complex data analysis, much like a human would.
Experts at the summit showcased how agentic AI can enhance operational efficiency, improve customer engagement, and drive innovation across industries. Presentations highlighted real-world applications, demonstrating how businesses can leverage this technology to gain a competitive edge. The discussions also touched upon the ethical implications of deploying such powerful AI systems, emphasizing the need for responsible implementation.
As organizations continue to explore the capabilities of agentic AI, the summit served as a pivotal platform for sharing insights and strategies. The consensus among attendees was clear: embracing agentic AI is essential for future growth and success in an increasingly digital landscape.
MORE NEWS
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...